Article
RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
Leukemia research - 1 Aug 2011
Liu Liang, Yang Lin, Mi Yingchang, Wang Jianxiang, Li Jianyong, Zhang Yue, Ma Xiaotang, Qin Tiejun, Xu Zefeng, Xiao Zhijian
Abstract excerpt
DNA double-strand break repair via homologous recombination (HR) is essential in maintaining genetic integrity, and may modulate susceptibility to the development of acute myeloid leukemia (AML) and influence outcomes of AML. This study was designed to evaluate the effects of polymorphisms in HR repair genes RAD51 and XRCC3 on the risk and treatment outcomes of inv(16)/t(16;16)/CBFβ-MYH11(+) AML. The distribution...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
